Firas Al Solaiman, MD
Interventional Cardiology · Birmingham, ALNPI 1679507875
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $555 of the $630 with a category attached, or 88.1%. 6 manufacturers reported payments, led by Abbott at 54.8% of the total. 2025 is the largest year on record at $196, 2.6 times the $75 reported in 2019. That places this record below the midpoint for interventional cardiology clinicians in AL, where the typical reported total is $6,630.
Across 27 payments — averaging $23.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$345
- W. L. Gore & Associates, Inc.$157
- Terumo Medical Corporation$75
- Edwards Lifesciences$19
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$17
- Siemens Medical Solutions USA, Inc.$16
What the payments were for
- Consulting fees$7512%
- Food & beverage$55588%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 22 | $345 |
| W. L. Gore & Associates, Inc. | 1 | $157 |
| Terumo Medical Corporation | 1 | $75 |
| Edwards Lifesciences | 1 | $19 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $17 |
| Siemens Medical Solutions USA, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$630 in reported general payments places this provider in the 10th percentile of 109 interventional cardiology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Praluent PenAlirocumab | 15 | $7,095 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 11 | $126 |
| Atorvastatin Calcium | 20 | $115 |
| Carvedilol | 12 | $109 |
| Amlodipine Besylate | 12 | $80 |
| Pantoprazole Sodium | 14 | $39 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Birmingham
- Gary RoubinBirmingham$157K
- Robert FosterBirmingham$90K
- Hasan GuvenBirmingham$86K
- Abdullah MahmoodBirmingham$61K
- Ali EbrahimiBirmingham$55K
- Jacob TownsendBirmingham$52K
- Kamran AliBirmingham$47K
- Mouhamed SabouniBirmingham$44K
- David SchultzBirmingham$19K
- Tushar MishraBirmingham$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.